SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...

Several dozen people gathered at Clovis Community Medical Center to celebrate patients living with a Left Ventricular Assist ...

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit ...

The writers have been pulling at our heartstrings for two decades now, but sometimes, they just rip our hearts into shreds ...

Jeshwanth Kundem, Engineering Project Leader at nVent, outlines considerations when selecting expansion tanks for CDUs.

Patients with heart failure are often advised to limit or avoid alcohol consumption altogether, as it can interfere with ...

Abbott has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

ABT has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options. The TEAM-HF trial is ...